Human Genetics

, Volume 130, Issue 1, pp 123–148 | Cite as

Risk factors for autism: translating genomic discoveries into diagnostics

Review Paper

Abstract

Autism spectrum disorders (ASDs) are a group of conditions characterized by impairments in communication and reciprocal social interaction, and the presence of restricted and repetitive behaviors. The spectrum of autistic features is variable, with severity of symptoms ranging from mild to severe, sometimes with poor clinical outcomes. Twin and family studies indicate a strong genetic basis for ASD susceptibility. Recent progress in defining rare highly penetrant mutations and copy number variations as ASD risk factors has prompted early uptake of these research findings into clinical diagnostics, with microarrays becoming a ‘standard of care’ test for any ASD diagnostic work-up. The ever-changing landscape of the generation of genomic data coupled with the vast heterogeneity in cause and expression of ASDs (further influenced by issues of penetrance, variable expressivity, multigenic inheritance and ascertainment) creates complexity that demands careful consideration of how to apply this knowledge. Here, we discuss the scientific, ethical, policy and communication aspects of translating the new discoveries into clinical and diagnostic tools for promoting the well-being of individuals and families with ASDs.

References

  1. Abrahams BS, Geschwind DH (2008) Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 9:341–355. doi:10.1038/nrg2346 PubMedCrossRefGoogle Scholar
  2. Abrahams BS, Geschwind DH (2010) Connecting genes to brain in the autism spectrum disorders. Arch Neurol 67:395–399. doi:10.1001/archneurol.2010.47 PubMedCrossRefGoogle Scholar
  3. Addington AM, Gauthier J, Piton A, Hamdan FF, Raymond A, Gogtay N, Miller R, Tossell J, Bakalar J, Germain G, Gochman P, Long R, Rapoport JL, Rouleau GA (2011) A novel frameshift mutation in UPF3B identified in brothers affected with childhood onset schizophrenia and autism spectrum disorders. Mol Psychiatry 16:238–239. doi:10.1038/mp.2010.59 PubMedCrossRefGoogle Scholar
  4. Ali-Khan SE, Daar AS, Shuman C, Ray PN, Scherer SW (2009) Whole genome scanning: resolving clinical diagnosis and management amidst complex data. Pediatr Res 66:357–363. doi:10.1203/PDR.0b013e3181b0cbd8 PubMedCrossRefGoogle Scholar
  5. Altevogt BM, Hanson SL, Leshner AI (2008) Autism and the environment: challenges and opportunities for research. Pediatrics 121:1225–1229. doi:10.1542/peds.2007-3000 PubMedCrossRefGoogle Scholar
  6. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition—Text Revision (DSMIV-TR). American Psychiatric Association, Washington, DCCrossRefGoogle Scholar
  7. Anney R, Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Sykes N, Pagnamenta AT, Almeida J, Bacchelli E, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Carson AR, Casallo G, Casey J, Chu SH, Cochrane L, Corsello C, Crawford EL, Crossett A, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Melhem NM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Piven J, Posey DJ, Poustka A, Poustka F et al (2010) A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet 19:4072–4082. doi:10.1093/hmg/ddq307 PubMedCrossRefGoogle Scholar
  8. Association of Clinical Cytogenetics (2009) Professional guidelines for clinical cytogenetics: constitutional array CGH best practice guidelines (2009) v1.00. http://www.cytogenetics.org.uk/prof_standards/acc_const_arrayCGH_bp_jan2009_1.00.pdf. Accessed April 18 2011
  9. Autism and Developmental Disabilities Monitoring Network (2009) Prevalence of autism spectrum disorders—Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ 58:1–20 ss5810a1[pii]Google Scholar
  10. Autism Speaks (2009) Autism Speaks Sponsored Workshop Provides Guidelines for Risk Factor Dissemination. http://www.autismspeaks.org/science/science_news/risk_factors_meeting_report.php. Accessed 18 April 2011
  11. Bakkaloglu B, O’Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM, Chawarska K, Klin A, Ercan-Sencicek AG, Stillman AA, Tanriover G, Abrahams BS, Duvall JA, Robbins EM, Geschwind DH, Biederer T, Gunel M, Lifton RP, State MW (2008) Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 82:165–173. doi:10.1016/j.ajhg.2007.09.017 PubMedCrossRefGoogle Scholar
  12. Beaudet AL (2010) Which way for genetic-test regulation? Leave test interpretation to specialists. Nature 466:816–817. doi:10.1038/466816a PubMedCrossRefGoogle Scholar
  13. Beaudet AL, Belmont JW (2008) Array-based DNA diagnostics: let the revolution begin. Annu Rev Med 59:113–129. doi:10.1146/annurev.med.59.012907.101800 PubMedCrossRefGoogle Scholar
  14. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, Roberts W, Szatmari P, Pinto D, Bonin M, Riess A, Engels H, Sprengel R, Scherer SW, Rappold GA (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42:489–491. doi:10.1038/ng.589 PubMedCrossRefGoogle Scholar
  15. Betancur C (2011) Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380:42–77. doi:10.1016/j.brainres.2010.11.078 PubMedCrossRefGoogle Scholar
  16. Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K, Saeed S, Hamilton-Shield J, Clayton-Smith J, O’Rahilly S, Hurles ME, Farooqi IS (2010) Large, rare chromosomal deletions associated with severe early-onset obesity. Nature 463:666–670. doi:10.1038/nature08689 PubMedCrossRefGoogle Scholar
  17. Botkin JR, Teutsch SM, Kaye CI, Hayes M, Haddow JE, Bradley LA, Szegda K, Dotson WD (2010) Outcomes of interest in evidence-based evaluations of genetic tests. Genet Med 12:228–235. doi:10.1097/GIM.0b013e3181cdde04 PubMedCrossRefGoogle Scholar
  18. Bourgeron T (2009) A synaptic trek to autism. Curr Opin Neurobiol 19:231–234. doi:10.1016/j.conb.2009.06.003 PubMedCrossRefGoogle Scholar
  19. Bradley WE, Raelson JV, Dubois DY, Godin E, Fournier H, Prive C, Allard R, Pinchuk V, Lapalme M, Paulussen RJ, Belouchi A (2010) Hotspots of large rare deletions in the human genome. PLoS One 5:e9401. doi:10.1371/journal.pone.0009401 PubMedCrossRefGoogle Scholar
  20. Brunetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA, Sahoo T, Lalani SR, Graham B, Lee B, Shinawi M, Shen J, Kang SH, Pursley A, Lotze T, Kennedy G, Lansky-Shafer S, Weaver C, Roeder ER, Grebe TA, Arnold GL, Hutchison T, Reimschisel T, Amato S, Geragthy MT, Innis JW, Obersztyn E, Nowakowska B, Rosengren SS, Bader PI, Grange DK, Naqvi S, Garnica AD, Bernes SM, Fong CT, Summers A, Walters WD, Lupski JR, Stankiewicz P, Cheung SW, Patel A (2008) Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 40:1466–1471. doi:10.1038/ng.279 PubMedCrossRefGoogle Scholar
  21. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI, Alvarez Retuerto AI, Imielinski M, Hadley D, Bradfield JP, Kim C, Gidaya NB, Lindquist I, Hutman T, Sigman M, Kustanovich V, Lajonchere CM, Singleton A, Kim J, Wassink TH, McMahon WM, Owley T, Sweeney JA, Coon H, Nurnberger JI, Li M, Cantor RM, Minshew NJ, Sutcliffe JS, Cook EH, Dawson G, Buxbaum JD, Grant SF, Schellenberg GD, Geschwind DH, Hakonarson H (2009) Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 5:e1000536. doi:10.1371/journal.pgen.1000536 PubMedCrossRefGoogle Scholar
  22. Buchanan JA, Scherer SW (2008) Contemplating effects of genomic structural variation. Genet Med 10:639–647. doi:10.1097/GIM.0b013e318183f848 PubMedCrossRefGoogle Scholar
  23. Buchanan JA, Carson AR, Chitayat D, Malkin D, Meyn MS, Ray PN, Shuman C, Weksberg R, Scherer SW (2009) The cycle of genome-directed medicine. Genome Med 1:16. doi:10.1186/gm16 PubMedCrossRefGoogle Scholar
  24. Carayol J, Schellenberg GD, Tores F, Hager J, Ziegler A, Dawson G (2010) Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk. Mol Autism 1:4. doi:10.1186/2040-2392-1-4 PubMedCrossRefGoogle Scholar
  25. Caronna EB, Milunsky JM, Tager-Flusberg H (2008) Autism spectrum disorders: clinical and research frontiers. Arch Dis Child 93:518–523. doi:10.1136/adc.2006.115337 PubMedCrossRefGoogle Scholar
  26. Carter M, Nikkel S, Fernandez B, Marshall C, Noor A, Lionel A, Prasad A, Pinto D, Joseph-George A, Noakes C, Fairbrother-Davies C, Roberts W, Vincent J, Weksberg R, Scherer S (2010) Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Clin Genet. doi:10.1111/j.1399-0004.2010.01578.x
  27. CCMG (2009) CCMG Position Statement: Use of array genomic hybridization technology in constitutional genetic diagnosis in Canada. http://www.ccmg-ccgm.org/pdf/policy/aCGH%20for%20pch%20sept%2009.pdf. Accessed April 18 2011
  28. Ching MS, Shen Y, Tan WH, Jeste SS, Morrow EM, Chen X, Mukaddes NM, Yoo SY, Hanson E, Hundley R, Austin C, Becker RE, Berry GT, Driscoll K, Engle EC, Friedman S, Gusella JF, Hisama FM, Irons MB, Lafiosca T, LeClair E, Miller DT, Neessen M, Picker JD, Rappaport L, Rooney CM, Sarco DP, Stoler JM, Walsh CA, Wolff RR, Zhang T, Nasir RH, Wu BL (2010) Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet B Neuropsychiatr Genet 153B:937–947. doi:10.1002/ajmg.b.31063 PubMedGoogle Scholar
  29. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S, Badner JA, Matsui S, Conroy J, McQuaid D, Gergel J, Hatchwell E, Gilliam TC, Gershon ES, Nowak NJ, Dobyns WB, Cook EH Jr (2008) Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63:1111–1117. doi:10.1016/j.biopsych.2008.01.009 PubMedCrossRefGoogle Scholar
  30. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, Sullivan PF (2009) Genomewide association studies: history, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166:540–556. doi:10.1176/appi.ajp.2008.08091354 PubMedCrossRefGoogle Scholar
  31. Cook EH Jr, Scherer SW (2008) Copy-number variations associated with neuropsychiatric conditions. Nature 455:919–923. doi:10.1038/nature07458 PubMedCrossRefGoogle Scholar
  32. Crespi B, Stead P, Elliot M (2010) Evolution in health and medicine Sackler colloquium: comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 107(Suppl 1):1736–1741. doi:10.1073/pnas.0906080106 PubMedCrossRefGoogle Scholar
  33. Dawson G (2008) Early behavioral intervention, brain plasticity, and the prevention of autism spectrum disorder. Dev Psychopathol 20:775–803. doi:10.1017/S0954579408000370 PubMedCrossRefGoogle Scholar
  34. Dawson G (2010) Recent advances in research on early detection, causes, biology, and treatment of autism spectrum disorders. Curr Opin Neurol 23:95–96. doi:10.1097/WCO.0b013e3283377644 PubMedCrossRefGoogle Scholar
  35. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, Donaldson A, Varley J (2010) Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 125:e17–e23. doi:10.1542/peds.2009-0958 PubMedCrossRefGoogle Scholar
  36. Devlin B, Melhem N, Roeder K (2011) Do common variants play a role in risk for autism? Evidence and theoretical musings. Brain Res 1380:78–84. doi:10.1016/j.brainres.2010.11.026 PubMedCrossRefGoogle Scholar
  37. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:25–27. doi:10.1038/ng1933 PubMedCrossRefGoogle Scholar
  38. El-Fishawy P, State MW (2010) The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am 33:83–105. doi:10.1016/j.psc.2009.12.002 PubMedCrossRefGoogle Scholar
  39. Fassio A, Patry L, Congia S, Onofri F, Piton A, Gauthier J, Pozzi D, Messa M, Defranchi E, Fadda M, Corradi A, Baldelli P, Lapointe L, St-Onge J, Meloche C, Mottron L, Valtorta F, Khoa Nguyen D, Rouleau GA, Benfenati F, Cossette P (2011) SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet 20:2297–2307. doi:10.1093/hmg/ddr122 PubMedCrossRefGoogle Scholar
  40. Fernandez BA, Roberts W, Chung B, Weksberg R, Meyn S, Szatmari P, Joseph-George AM, Mackay S, Whitten K, Noble B, Vardy C, Crosbie V, Luscombe S, Tucker E, Turner L, Marshall CR, Scherer SW (2010) Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet 47:195–203. doi:10.1136/jmg.2009.069369 PubMedCrossRefGoogle Scholar
  41. Filges I, Rothlisberger B, Blattner A, Boesch N, Demougin P, Wenzel F, Huber AR, Heinimann K, Weber P, Miny P (2011) Deletion in Xp22.11: PTCHD1 is a candidate gene for X-linked intellectual disability with or without autism. Clin Genet 79:79–85. doi:10.1111/j.1399-0004.2010.01590.x PubMedCrossRefGoogle Scholar
  42. Food and Drug Administration (2009) FDA’s strategic plan for risk communication. http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/UCM183683.pdf. Accessed 18 April 2011
  43. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R (2010) Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry 19:169–178. doi:10.1007/s00787-009-0076-x PubMedCrossRefGoogle Scholar
  44. Gauthier J, Champagne N, Lafreniere RG, Xiong L, Spiegelman D, Brustein E, Lapointe M, Peng H, Cote M, Noreau A, Hamdan FF, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Joober R, Fathalli F, Mouaffak F, Haghighi AP, Neri C, Dube MP, Samuels ME, Marineau C, Stone EA, Awadalla P, Barker PA, Carbonetto S, Drapeau P, Rouleau GA (2010) De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci USA 107:7863–7868. doi:10.1073/pnas.0906232107 PubMedCrossRefGoogle Scholar
  45. Gauthier J, Siddiqui TJ, Huashan P, Yokomaku D, Hamdan FF, Champagne N, Lapointe M, Spiegelman D, Noreau A, Lafreniere RG, Fathalli F, Joober R, Krebs MO, Delisi LE, Mottron L, Fombonne E, Michaud JL, Drapeau P, Carbonetto S, Craig AM, Rouleau GA (2011) Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. doi:10.1007/s00439-011-0975-z
  46. GeneTests (1993) Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle, 1993–2011. http://www.genetests.org. Accessed 18 April 2011
  47. Georgiades S, Szatmari P, Zwaigenbaum L, Duku E, Bryson S, Roberts W, Goldberg J, Mahoney W (2007) Structure of the autism symptom phenotype: a proposed multidimensional model. J Am Acad Child Adolesc Psychiatry 46:188–196. doi:10.1097/01.chi.0000242236.90763.7f PubMedCrossRefGoogle Scholar
  48. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, Glaberson W, Flory J, Otieno F, Garris M, Soorya L, Klei L, Piven J, Meyer KJ, Anagnostou E, Sakurai T, Game RM, Rudd DS, Zurawiecki D, McDougle CJ, Davis LK, Miller J, Posey DJ, Michaels S, Kolevzon A, Silverman JM, Bernier R, Levy SE, Schultz RT, Dawson G, Owley T, McMahon WM, Wassink TH, Sweeney JA, Nurnberger JI, Coon H, Sutcliffe JS, Minshew NJ, Grant SF, Bucan M, Cook EH, Buxbaum JD, Devlin B, Schellenberg GD, Hakonarson H (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569–573. doi:10.1038/nature07953 PubMedCrossRefGoogle Scholar
  49. Grandjean P, Landrigan PJ (2006) Developmental neurotoxicity of industrial chemicals. Lancet 368:2167–2178. doi:10.1016/S0140-6736(06)69665-7 PubMedCrossRefGoogle Scholar
  50. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, Laumonnier F, Odent S, Le Vacon G, Joly-Helas G, David V, Bendavid C, Pinoit JM, Henry C, Impallomeni C, Germano E, Tortorella G, Di Rosa G, Barthelemy C, Andres C, Faivre L, Frebourg T, Saugier Veber P, Campion D (2009) Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66:947–956. doi:10.1001/archgenpsychiatry.2009.80 PubMedCrossRefGoogle Scholar
  51. Hamdan FF, Daoud H, Rochefort D, Piton A, Gauthier J, Langlois M, Foomani G, Dobrzeniecka S, Krebs MO, Joober R, Lafreniere RG, Lacaille JC, Mottron L, Drapeau P, Beauchamp MH, Phillips MS, Fombonne E, Rouleau GA, Michaud JL (2010) De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet 87:671–678. doi:10.1016/j.ajhg.2010.09.017 PubMedCrossRefGoogle Scholar
  52. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO, Joober R, Lacaille JC, Nadeau A, Milunsky JM, Wang Z, Carmant L, Mottron L, Beauchamp MH, Rouleau GA, Michaud JL (2011) De Novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry 69:898–901. doi:10.1016/j.biopsych.2010.11.015 PubMedCrossRefGoogle Scholar
  53. Hayeems RZ, Miller FA, Li L, Bytautas JP (2011) Not so simple: a quasi-experimental study of how researchers adjudicate genetic research results. Eur J Hum Genet. doi:10.1038/ejhg.2011.34
  54. Jacquemont ML, Sanlaville D, Redon R, Raoul O, Cormier-Daire V, Lyonnet S, Amiel J, Le Merrer M, Heron D, de Blois MC, Prieur M, Vekemans M, Carter NP, Munnich A, Colleaux L, Philippe A (2006) Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet 43:843–849. doi:10.1136/jmg.2006.043166 PubMedCrossRefGoogle Scholar
  55. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T (2003) Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27–29. doi:10.1038/ng1136 PubMedCrossRefGoogle Scholar
  56. Johnson CP, Myers SM (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183–1215. doi:10.1542/peds.2007-2361 PubMedCrossRefGoogle Scholar
  57. Johnson S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N (2010) Psychiatric disorders in extremely preterm children: longitudinal finding at age 11 years in the EPICure study. J Am Acad Child Adolesc Psychiatry 49:453e1–463e1. 00004583-201005000-00006[pii]Google Scholar
  58. Kanner L, Eisenberg L (1958) Child psychiatry, mental deficiency. Am J Psychiatry 114:609–615PubMedGoogle Scholar
  59. Khoury MJ, Feero WG, Reyes M, Citrin T, Freedman A, Leonard D, Burke W, Coates R, Croyle RT, Edwards K, Kardia S, McBride C, Manolio T, Randhawa G, Rasooly R, St Pierre J, Terry S (2009) The genomic applications in practice and prevention network. Genet Med 11:488–494. doi:10.1097/GIM.0b013e3181a551cc PubMedCrossRefGoogle Scholar
  60. Kirov G, Rujescu D, Ingason A, Collier DA, O’Donovan MC, Owen MJ (2009) Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35:851–854. doi:10.1093/schbul/sbp079 PubMedCrossRefGoogle Scholar
  61. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC, Nowak NJ, Cook EH, Jr, Dobyns WB, Christian SL (2008) Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 17:628–638. doi:10.1093/hmg/ddm376 Google Scholar
  62. Kumar RA, Marshall CR, Badner JA, Babatz TD, Mukamel Z, Aldinger KA, Sudi J, Brune CW, Goh G, Karamohamed S, Sutcliffe JS, Cook EH, Geschwind DH, Dobyns WB, Scherer SW, Christian SL (2009) Association and mutation analyses of 16p11.2 autism candidate genes. PLoS One 4:e4582. doi:10.1371/journal.pone.0004582
  63. Lander ES (2011) Initial impact of the sequencing of the human genome. Nature 470:187–197. doi:10.1038/nature09792 PubMedCrossRefGoogle Scholar
  64. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, Raynaud M, Ronce N, Lemonnier E, Calvas P, Laudier B, Chelly J, Fryns JP, Ropers HH, Hamel BC, Andres C, Barthelemy C, Moraine C, Briault S (2004) X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74:552–557. doi:10.1086/382137 PubMedCrossRefGoogle Scholar
  65. Lee C, Scherer SW (2010) The clinical context of copy number variation in the human genome. Expert Rev Mol Med 12:e8. doi:10.1017/S1462399410001390 PubMedCrossRefGoogle Scholar
  66. Lineagen (2011) Opening autism: digital health platform. Copyright, Lineagen, 2010. http://www.lineagen.com/Diagnostic_Services___Opening_Autism.html. Accessed 18 April 2011
  67. Lintas C, Persico AM (2009) Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist. J Med Genet 46:1–8. doi:10.1136/jmg.2008.060871 PubMedCrossRefGoogle Scholar
  68. Lord C, Bishop SL (2009) The autism spectrum: definitions, assessment and diagnoses. Br J Hosp Med (Lond) 70:132–135Google Scholar
  69. Manning M, Hudgins L (2010) Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 12:742–745. doi:10.1097/GIM.0b013e3181f8baad PubMedGoogle Scholar
  70. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461:747–753. doi:10.1038/nature08494 PubMedCrossRefGoogle Scholar
  71. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, Summers A, Gibbons CA, Teebi A, Chitayat D, Weksberg R, Thompson A, Vardy C, Crosbie V, Luscombe S, Baatjes R, Zwaigenbaum L, Roberts W, Fernandez B, Szatmari P, Scherer SW (2008) Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 82:477–488. doi:10.1016/j.ajhg.2007.12.009 PubMedCrossRefGoogle Scholar
  72. McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, Krause V, Kumar RA, Grozeva D, Malhotra D, Walsh T, Zackai EH, Kaplan P, Ganesh J, Krantz ID, Spinner NB, Roccanova P, Bhandari A, Pavon K, Lakshmi B, Leotta A, Kendall J, Lee YH, Vacic V, Gary S, Iakoucheva LM, Crow TJ, Christian SL, Lieberman JA, Stroup TS, Lehtimaki T, Puura K, Haldeman-Englert C, Pearl J, Goodell M, Willour VL, Derosse P, Steele J, Kassem L, Wolff J, Chitkara N, McMahon FJ, Malhotra AK, Potash JB, Schulze TG, Nothen MM, Cichon S, Rietschel M, Leibenluft E, Kustanovich V, Lajonchere CM, Sutcliffe JS, Skuse D, Gill M, Gallagher L, Mendell NR, Craddock N, Owen MJ, O’Donovan MC, Shaikh TH, Susser E, Delisi LE, Sullivan PF, Deutsch CK, Rapoport J, Levy DL, King MC, Sebat J (2009) Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet 41:1223–1227. doi:10.1038/ng.474 PubMedCrossRefGoogle Scholar
  73. McCarty CA, Wilke RA (2010) Biobanking and pharmacogenomics. Pharmacogenomics 11:637–641. doi:10.2217/pgs.10.13 PubMedCrossRefGoogle Scholar
  74. Mefford HC, Sharp AJ, Baker C, Itsara A, Jiang Z, Buysse K, Huang S, Maloney VK, Crolla JA, Baralle D, Collins A, Mercer C, Norga K, de Ravel T, Devriendt K, Bongers EM, de Leeuw N, Reardon W, Gimelli S, Bena F, Hennekam RC, Male A, Gaunt L, Clayton-Smith J, Simonic I, Park SM, Mehta SG, Nik-Zainal S, Woods CG, Firth HV, Parkin G, Fichera M, Reitano S, Lo Giudice M, Li KE, Casuga I, Broomer A, Conrad B, Schwerzmann M, Raber L, Gallati S, Striano P, Coppola A, Tolmie JL, Tobias ES, Lilley C, Armengol L, Spysschaert Y, Verloo P, De Coene A, Goossens L, Mortier G, Speleman F, van Binsbergen E, Nelen MR, Hochstenbach R, Poot M, Gallagher L, Gill M, McClellan J, King MC, Regan R, Skinner C, Stevenson RE, Antonarakis SE, Chen C, Estivill X, Menten B, Gimelli G, Gribble S, Schwartz S, Sutcliffe JS, Walsh T, Knight SJ, Sebat J, Romano C, Schwartz CE, Veltman JA, de Vries BB, Vermeesch JR, Barber JC, Willatt L, Tassabehji M, Eichler EE (2008) Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. New Engl J Med 359:1685–1699. doi:10.1056/NEJMoa0805384 PubMedCrossRefGoogle Scholar
  75. Merikangas AK, Corvin AP, Gallagher L (2009) Copy-number variants in neurodevelopmental disorders: promises and challenges. Trends Genet 25:536–544. doi:10.1016/j.tig.2009.10.006 PubMedCrossRefGoogle Scholar
  76. Miles JH, Takahashi TN, Bagby S, Sahota PK, Vaslow DF, Wang CH, Hillman RE, Farmer JE (2005) Essential versus complex autism: definition of fundamental prognostic subtypes. Am J Med Genet A 135:171–180. doi:10.1002/ajmg.a.30590 PubMedGoogle Scholar
  77. Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, Scherer SW, Spinner NB, Stavropoulos DJ, Tepperberg JH, Thorland EC, Vermeesch JR, Waggoner DJ, Watson MS, Martin CL, Ledbetter DH (2010a) Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86:749–764. doi:10.1016/j.ajhg.2010.04.006 PubMedCrossRefGoogle Scholar
  78. Miller FA, Hayeems RZ, Bytautas JP (2010b) What is a meaningful result? Disclosing the results of genomic research in autism to research participants. Eur J Hum Genet 18:867–871. doi:10.1038/ejhg.2010.34 PubMedCrossRefGoogle Scholar
  79. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW (2007) Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81:1289–1297. doi:10.1086/522590 PubMedCrossRefGoogle Scholar
  80. Moreno-De-Luca D, Mulle JG, Kaminsky EB, Sanders SJ, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, Weik L, Guy L, Care ME, Morel CF, Boni C, Salbert BA, Chandrareddy A, Demmer LA, Chow EW, Surti U, Aradhya S, Pickering DL, Golden DM, Sanger WG, Aston E, Brothman AR, Gliem TJ, Thorland EC, Ackley T, Iyer R, Huang S, Barber JC, Crolla JA, Warren ST, Martin CL, Ledbetter DH (2010) Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia. Am J Hum Genet 87:618–630. doi:10.1016/j.ajhg.2010.10.004 PubMedCrossRefGoogle Scholar
  81. Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, Hill RS, Mukaddes NM, Balkhy S, Gascon G, Hashmi A, Al-Saad S, Ware J, Joseph RM, Greenblatt R, Gleason D, Ertelt JA, Apse KA, Bodell A, Partlow JN, Barry B, Yao H, Markianos K, Ferland RJ, Greenberg ME, Walsh CA (2008) Identifying autism loci and genes by tracing recent shared ancestry. Science 321:218–223. doi:10.1126/science.1157657 PubMedCrossRefGoogle Scholar
  82. Myers RA, Casals F, Gauthier J, Hamdan FF, Keebler J, Boyko AR, Bustamante CD, Piton AM, Spiegelman D, Henrion E, Zilversmit M, Hussin J, Quinlan J, Yang Y, Lafreniere RG, Griffing AR, Stone EA, Rouleau GA, Awadalla P (2011) A population genetic approach to mapping neurological disorder genes using deep resequencing. PLoS Genet 7:e1001318. doi:10.1371/journal.pgen.1001318 PubMedCrossRefGoogle Scholar
  83. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC (2007) The epidemiology of autism spectrum disorders. Annu Rev Public Health 28:235–258. doi:10.1146/annurev.publhealth.28.021406.144007 PubMedCrossRefGoogle Scholar
  84. Noor A, Whibley A, Marshall CR, Gianakopoulos PJ, Piton A, Carson AR, Orlic-Milacic M, Lionel AC, Sato D, Pinto D, Drmic I, Noakes C, Senman L, Zhang X, Mo R, Gauthier J, Crosbie J, Pagnamenta AT, Munson J, Estes AM, Fiebig A, Franke A, Schreiber S, Stewart AF, Roberts R, McPherson R, Guter SJ, Cook EH, Jr, Dawson G, Schellenberg GD, Battaglia A, Maestrini E, Jeng L, Hutchison T, Rajcan-Separovic E, Chudley AE, Lewis SM, Liu X, Holden JJ, Fernandez B, Zwaigenbaum L, Bryson SE, Roberts W, Szatmari P, Gallagher L, Stratton MR, Gecz J, Brady AF, Schwartz CE, Schachar RJ, Monaco AP, Rouleau GA, Hui CC, Lucy Raymond F, Scherer SW, Vincent JB (2010) Disruption at the PTCHD1 Locus on Xp22.11 in Autism spectrum disorder and intellectual disability. Sci Transl Med 2:49ra68. doi:10.1126/scitranslmed.3001267
  85. O’Roak BJ, State MW (2008) Autism genetics: strategies, challenges, and opportunities. Autism Res 1:4–17. doi:10.1002/aur.3 PubMedCrossRefGoogle Scholar
  86. Pagnamenta AT, Bacchelli E, de Jonge MV, Mirza G, Scerri TS, Minopoli F, Chiocchetti A, Ludwig KU, Hoffmann P, Paracchini S, Lowy E, Harold DH, Chapman JA, Klauck SM, Poustka F, Houben RH, Staal WG, Ophoff RA, O’Donovan MC, Williams J, Nothen MM, Schulte-Korne G, Deloukas P, Ragoussis J, Bailey AJ, Maestrini E, Monaco AP (2010) Characterization of a family with rare deletions in CNTNAP5 and DOCK4 suggests novel risk loci for autism and dyslexia. Biol Psychiatry 68:320–328. doi:10.1016/j.biopsych.2010.02.002 PubMedCrossRefGoogle Scholar
  87. Pagnamenta AT, Khan H, Walker S, Gerrelli D, Wing K, Bonaglia MC, Giorda R, Berney T, Mani E, Molteni M, Pinto D, Le Couteur A, Hallmayer J, Sutcliffe JS, Szatmari P, Paterson AD, Scherer SW, Vieland VJ, Monaco AP (2011) Rare familial 16q21 microdeletions under a linkage peak implicate cadherin 8 (CDH8) in susceptibility to autism and learning disability. J Med Genet 48:48–54. doi:10.1136/jmg.2010.079426 PubMedCrossRefGoogle Scholar
  88. Patterson PH (2011) Maternal infection and immune involvement in autism. Trends Mol Med. doi:10.1016/j.molmed.2011.03.001
  89. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, Almeida J, Bacchelli E, Bader GD, Bailey AJ, Baird G, Battaglia A, Berney T, Bolshakova N, Bolte S, Bolton PF, Bourgeron T, Brennan S, Brian J, Bryson SE, Carson AR, Casallo G, Casey J, Chung BH, Cochrane L, Corsello C, Crawford EL, Crossett A, Cytrynbaum C, Dawson G, de Jonge M, Delorme R, Drmic I, Duketis E, Duque F, Estes A, Farrar P, Fernandez BA, Folstein SE, Fombonne E, Freitag CM, Gilbert J, Gillberg C, Glessner JT, Goldberg J, Green A, Green J, Guter SJ, Hakonarson H, Heron EA, Hill M, Holt R, Howe JL, Hughes G, Hus V, Igliozzi R, Kim C, Klauck SM, Kolevzon A, Korvatska O, Kustanovich V, Lajonchere CM, Lamb JA, Laskawiec M, Leboyer M, Le Couteur A, Leventhal BL, Lionel AC, Liu XQ, Lord C, Lotspeich L, Lund SC, Maestrini E, Mahoney W, Mantoulan C, Marshall CR, McConachie H, McDougle CJ, McGrath J, McMahon WM, Merikangas A, Migita O, Minshew NJ, Mirza GK, Munson J, Nelson SF, Noakes C, Noor A, Nygren G, Oliveira G, Papanikolaou K, Parr JR, Parrini B, Paton T, Pickles A, Pilorge M et al (2010) Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368–372. doi:10.1038/nature09146 PubMedCrossRefGoogle Scholar
  90. Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T, Lionel AC, Thiruvahindrapuram B, MacDonald JR, Mills R, Prasad A, Noonan K, Gribble S, Prigmore E, Donahoe PK, Smith RS, Park JH, Hurles ME, Carter NP, Lee C, Scherer SW, Feuk L (2011) Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol. doi:10.1038/nbt.1852
  91. Piton A, Gauthier J, Hamdan FF, Lafreniere RG, Yang Y, Henrion E, Laurent S, Noreau A, Thibodeau P, Karemera L, Spiegelman D, Kuku F, Duguay J, Destroismaisons L, Jolivet P, Cote M, Lachapelle K, Diallo O, Raymond A, Marineau C, Champagne N, Xiong L, Gaspar C, Riviere JB, Tarabeux J, Cossette P, Krebs MO, Rapoport JL, Addington A, Delisi LE, Mottron L, Joober R, Fombonne E, Drapeau P, Rouleau GA (2010) Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry. doi:10.1038/mp.2010.54
  92. Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C (2007) Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect 115:1482–1489. doi:10.1289/ehp.10168 PubMedGoogle Scholar
  93. Robison JE (2011) Be Different: Adventures of a Free-Range Aspergian with Practical Advice for Aspergians. Misfits, Families & Teachers. Crown Archetype, New YorkGoogle Scholar
  94. Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T, Picchioni M, Vassos E, Ettinger U, Bramon E, Murray R, Ruggeri M, Tosato S, Bonetto C, Steinberg S, Sigurdsson E, Sigmundsson T, Petursson H, Gylfason A, Olason PI, Hardarsson G, Jonsdottir GA, Gustafsson O, Fossdal R, Giegling I, Moller HJ, Hartmann AM, Hoffmann P, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Djurovic S, Melle I, Andreassen OA, Hansen T, Werge T, Kiemeney LA, Franke B, Veltman J, Buizer-Voskamp JE, Sabatti C, Ophoff RA, Rietschel M, Nothen MM, Stefansson K, Peltonen L, St Clair D, Stefansson H, Collier DA (2009) Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18:988–996. doi:10.1093/hmg/ddn351 PubMedGoogle Scholar
  95. Scherer SW, Lee C, Birney E, Altshuler DM, Eichler EE, Carter NP, Hurles ME, Feuk L (2007) Challenges and standards in integrating surveys of structural variation. Nat Genet 39:S7–S15. doi:10.1038/ng2093 PubMedCrossRefGoogle Scholar
  96. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimaki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M (2007) Strong association of de novo copy number mutations with autism. Science 316:445–449. doi:10.1126/science.1138659 PubMedCrossRefGoogle Scholar
  97. Seno MM, Hu P, Gwadry FG, Pinto D, Marshall CR, Casallo G, Scherer SW (2011) Gene and miRNA expression profiles in autism spectrum disorders. Brain Res 1380:85–97. doi:10.1016/j.brainres.2010.09.046 PubMedCrossRefGoogle Scholar
  98. Shelton JF, Tancredi DJ, Hertz-Picciotto I (2010) Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res 3:30–39. doi:10.1002/aur.116 PubMedCrossRefGoogle Scholar
  99. Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, Miller KJ, Frazier JA, Silverstein I, Picker J, Weissman L, Raffalli P, Jeste S, Demmer LA, Peters HK, Brewster SJ, Kowalczyk SJ, Rosen-Sheidley B, McGowan C, Duda AW 3rd, Lincoln SA, Lowe KR, Schonwald A, Robbins M, Hisama F, Wolff R, Becker R, Nasir R, Urion DK, Milunsky JM, Rappaport L, Gusella JF, Walsh CA, Wu BL, Miller DT (2010) Clinical genetic testing for patients with autism spectrum disorders. Pediatrics 125:e727–e735. doi:10.1542/peds.2009-1684 PubMedCrossRefGoogle Scholar
  100. Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA, Probst FJ, Craigen WJ, Graham BH, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez DL, Kozel BA, Sparagana S, Roeder ER, McGrew SG, Kurczynski TW, Allison LJ, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet AL, Cheung SW, Lupski JR (2010) Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 47:332–341. doi:10.1136/jmg.2009.073015 PubMedCrossRefGoogle Scholar
  101. Shlien A, Tabori U, Marshall CR, Pienkowska M, Feuk L, Novokmet A, Nanda S, Druker H, Scherer SW, Malkin D (2008) Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome. Proc Natl Acad Sci U S A 105:11264–11269. doi:10.1073/pnas.0802970105 PubMedCrossRefGoogle Scholar
  102. Simonoff E (1998) Genetic counseling in autism and pervasive developmental disorders. J Autism Dev Disord 28:447–456PubMedCrossRefGoogle Scholar
  103. Simons Foundation (2010) Simons VIP Connect: Simons variation in individuals project. Copyright, Simons Foundation, 2011. http://www.simonsvipconnect.org/. Accessed 18 April 2011
  104. State MW (2010) The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron 68:254–269. doi:10.1016/j.neuron.2010.10.004 PubMedCrossRefGoogle Scholar
  105. Stephenson DT, Fitzgerald LW (2010) Development of pharmacotherapies for autism spectrum disorders: a molecular medicine framework for neuropsychiatric drug discovery. Drugs Fut 35:1029CrossRefGoogle Scholar
  106. Szatmari P (2000) The classification of autism, Asperger’s syndrome, and pervasive developmental disorder. Can J Psychiatry 45:731–738PubMedGoogle Scholar
  107. Szatmari P, Jones MB, Zwaigenbaum L, MacLean JE (1998) Genetics of autism: overview and new directions. J Autism Dev Disord 28:351–368PubMedCrossRefGoogle Scholar
  108. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, Marshall CR, Scherer SW, Vieland VJ, Bartlett C, Mangin LV, Goedken R, Segre A, Pericak-Vance MA, Cuccaro ML, Gilbert JR, Wright HH, Abramson RK, Betancur C, Bourgeron T, Gillberg C, Leboyer M, Buxbaum JD, Davis KL, Hollander E, Silverman JM, Hallmayer J, Lotspeich L, Sutcliffe JS, Haines JL, Folstein SE, Piven J, Wassink TH, Sheffield V, Geschwind DH, Bucan M, Brown WT, Cantor RM, Constantino JN, Gilliam TC, Herbert M, Lajonchere C, Ledbetter DH, Lese-Martin C, Miller J, Nelson S, Samango-Sprouse CA, Spence S, State M, Tanzi RE, Coon H, Dawson G, Devlin B, Estes A, Flodman P, Klei L, McMahon WM, Minshew N, Munson J, Korvatska E, Rodier PM, Schellenberg GD, Smith M, Spence MA, Stodgell C, Tepper PG, Wijsman EM, Yu CE, Roge B, Mantoulan C, Wittemeyer K, Poustka A, Felder B, Klauck SM, Schuster C, Poustka F, Bolte S, Feineis-Matthews S, Herbrecht E, Schmotzer G, Tsiantis J, Papanikolaou K, Maestrini E, Bacchelli E, Blasi F, Carone S, Toma C, Van Engeland H, de Jonge M, Kemner C, Koop F, Langemeijer M et al (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319–328. doi:10.1038/ng1985 PubMedCrossRefGoogle Scholar
  109. Szatmari P, Bryson S, Duku E, Vaccarella L, Zwaigenbaum L, Bennett T, Boyle MH (2009) Similar developmental trajectories in autism and Asperger syndrome: from early childhood to adolescence. J Child Psychol Psychiatry 50:1459–1467. doi:10.1111/j.1469-7610.2009.02123.x PubMedCrossRefGoogle Scholar
  110. Tabor HK, Cho MK (2007) Ethical implications of array comparative genomic hybridization in complex phenotypes: points to consider in research. Genet Med 9:626–631. doi:10.1097/GIM.0b013e3181485688 PubMedCrossRefGoogle Scholar
  111. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, Berg AO (2009) The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med 11:3–14. doi:10.1097/GIM.0b013e318184137c PubMedCrossRefGoogle Scholar
  112. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, Coleman M, Leboyer M, Gillberg C, Bourgeron T (2010) Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26:363–372. doi:10.1016/j.tig.2010.05.007 PubMedCrossRefGoogle Scholar
  113. Veenstra-Vanderweele J, Christian SL, Cook EH Jr (2004) Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 5:379–405. doi:10.1146/annurev.genom.5.061903.180050 PubMedCrossRefGoogle Scholar
  114. Vermeesch JR, Fiegler H, de Leeuw N, Szuhai K, Schoumans J, Ciccone R, Speleman F, Rauch A, Clayton-Smith J, Van Ravenswaaij C, Sanlaville D, Patsalis PC, Firth H, Devriendt K, Zuffardi O (2007) Guidelines for molecular karyotyping in constitutional genetic diagnosis. Eur J Hum Genet 15:1105–1114. doi:10.1038/sj.ejhg.5201896 PubMedCrossRefGoogle Scholar
  115. Via E, Radua J, Cardoner N, Happe F, Mataix-Cols D (2011) Meta-analysis of gray matter abnormalities in autism spectrum disorder: should asperger disorder be subsumed under a broader umbrella of autistic spectrum disorder? Arch Gen Psychiatry 68:409–418. doi:10.1001/archgenpsychiatry.2011.27 PubMedCrossRefGoogle Scholar
  116. Volkmar FR, State M, Klin A (2009) Autism and autism spectrum disorders: diagnostic issues for the coming decade. J Child Psychol Psychiatry 50:108–115. doi:10.1111/j.1469-7610.2008.02010.x PubMedCrossRefGoogle Scholar
  117. Vorstman JA, van Daalen E, Jalali GR, Schmidt ER, Pasterkamp RJ, de Jonge M, Hennekam EA, Janson E, Staal WG, van der Zwaag B, Burbach JP, Kahn RS, Emanuel BS, van Engeland H, Ophoff RA (2011) A double hit implicates DIAPH3 as an autism risk gene. Mol Psychiatry 16:442–451. doi:10.1038/mp.2010.26 PubMedCrossRefGoogle Scholar
  118. Wallace KS, Rogers SJ (2010) Intervening in infancy: implications for autism spectrum disorders. J Child Psychol Psychiatry 51:1300–1320. doi:10.1111/j.1469-7610.2010.02308.x PubMedCrossRefGoogle Scholar
  119. Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, Falchi M, Chen F, Andrieux J, Lobbens S, Delobel B, Stutzmann F, El-Sayed Moustafa JS, Chevre JC, Lecoeur C, Vatin V, Bouquillon S, Buxton JL, Boute O, Holder-Espinasse M, Cuisset JM, Lemaitre MP, Ambresin AE, Brioschi A, Gaillard M, Giusti V, Fellmann F, Ferrarini A, Hadjikhani N, Campion D, Guilmatre A, Goldenberg A, Calmels N, Mandel JL, Le Caignec C, David A, Isidor B, Cordier MP, Dupuis-Girod S, Labalme A, Sanlaville D, Beri-Dexheimer M, Jonveaux P, Leheup B, Ounap K, Bochukova EG, Henning E, Keogh J, Ellis RJ, Macdermot KD, van Haelst MM, Vincent-Delorme C, Plessis G, Touraine R, Philippe A, Malan V, Mathieu-Dramard M, Chiesa J, Blaumeiser B, Kooy RF, Caiazzo R, Pigeyre M, Balkau B, Sladek R, Bergmann S, Mooser V, Waterworth D, Reymond A, Vollenweider P, Waeber G, Kurg A, Palta P, Esko T, Metspalu A, Nelis M, Elliott P, Hartikainen AL, McCarthy MI, Peltonen L, Carlsson L, Jacobson P, Sjostrom L, Huang N, Hurles ME, O’Rahilly S, Farooqi IS, Mannik K, Jarvelin MR, Pattou F, Meyre D, Walley AJ, Coin LJ, Blakemore AI, Froguel P, Beckmann JS (2010) A new highly penetrant form of obesity due to deletions on chromosome 16p11**2. Nature 463:671–675. doi:10.1038/nature08727 PubMedCrossRefGoogle Scholar
  120. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D, Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E, Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J, Estes A, Korvatska O, Piven J, Sonnenblick LI, Alvarez Retuerto AI, Herman EI, Dong H, Hutman T, Sigman M, Ozonoff S, Klin A, Owley T, Sweeney JA, Brune CW, Cantor RM, Bernier R, Gilbert JR, Cuccaro ML, McMahon WM, Miller J, State MW, Wassink TH, Coon H, Levy SE, Schultz RT, Nurnberger JI, Haines JL, Sutcliffe JS, Cook EH, Minshew NJ, Buxbaum JD, Dawson G, Grant SF, Geschwind DH, Pericak-Vance MA, Schellenberg GD, Hakonarson H (2009) Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528–533. doi:10.1038/nature07999 PubMedCrossRefGoogle Scholar
  121. Webb S (2010) Drugmakers dance with autism. Nat Biotechnol 28:772–774. doi:10.1038/nbt0810-772 PubMedCrossRefGoogle Scholar
  122. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ (2008) Association between microdeletion and microduplication at 16p11**2 and autism. N Engl J Med 358:667–675. doi:10.1056/NEJMoa075974 PubMedCrossRefGoogle Scholar
  123. Weiss LA, Arking DE, Daly MJ, Chakravarti A (2009) A genome-wide linkage and association scan reveals novel loci for autism. Nature 461:802–808. doi:10.1038/nature08490 PubMedCrossRefGoogle Scholar
  124. Yin Y, Shen WH (2008) PTEN: a new guardian of the genome. Oncogene 27:5443–5453. doi:10.1038/onc.2008.241 PubMedCrossRefGoogle Scholar
  125. Zhang D, Cheng L, Qian Y, Alliey-Rodriguez N, Kelsoe JR, Greenwood T, Nievergelt C, Barrett TB, McKinney R, Schork N, Smith EN, Bloss C, Nurnberger J, Edenberg HJ, Foroud T, Sheftner W, Lawson WB, Nwulia EA, Hipolito M, Coryell W, Rice J, Byerley W, McMahon F, Schulze TG, Berrettini W, Potash JB, Belmonte PL, Zandi PP, McInnis MG, Zollner S, Craig D, Szelinger S, Koller D, Christian SL, Liu C, Gershon ES (2009) Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry 14:376–380. doi:10.1038/mp.2008.144 PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.McLaughlin Centre and The Centre for Applied GenomicsThe Hospital for Sick ChildrenTorontoCanada
  2. 2.Department of Molecular GeneticsUniversity of TorontoTorontoCanada
  3. 3.Autism Speaks and Department of PsychiatryUniversity of North Carolina, Chapel HillChapel HillUSA

Personalised recommendations